AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. Is ABBV suitable for ethical investing? Looking to buy or sell AbbVie Inc. (ABBV)? AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. 1Y. AbbVie is currently trading at more than 40 times its earnings, but its forward price-to-earnings multiple, which factors in the company's future growth, and is expected by analysts to fall to just nine. ABBV earned $5.65 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.51. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? On corrections down, there will be some support from the lines at $104.27 and $103.52. ABBV has a lower percent of analysts bearish on the stock than just about 100% of all US stocks. ... Jim Cramer Says Sell Pfizer Stock Monday. ... Video. ... 2 Biotech Stocks to Buy on Solid Q2 Results. To make matters worse, the company's Rinvoq drug, which was highly touted by AbbVie executives, received a disappointing review from the Institute for Clinical and Economic Review, which said the drug had only "marginal clinical benefit" compared to Humira. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. The variance in analysts' estimates of ABBV is less than 81.6% of stocks in the large market cap category. AbbVie Inc (ABBV) is a Sell Score 50. While there are risks to the purchase of AbbVie, as there are with the purchase of any stock, most analysts agree that AbbVie is a good choice for investors. Buy or Sell this stock? Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Simply Wall St has no position in any stocks mentioned. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the AbbVie Inc stock. There's a great deal of uncertainty surrounding AbbVie's future, both with the drugs it has in development and its deal with Allergan, and that makes the healthcare stock too risky of a buy today, especially at its current valuation. Although investors didn't initially respond favorably to the deal, over the long term, AbbVie could enjoy significant benefits, the biggest of which is diversification. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Made In NYC | Skip Navigation. See what the analysts say. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. See Abbvie real time stock price, historical quotes and price charts. Although no specific date has been given, the two companies expect the deal to close "early 2020" which is when AbbVie's financials will begin including Allergan's results. With a good mix of revenue, AbbVie's numbers will not only get stronger as a result of the acquisition, but its product sales will also be much more diverse. AbbVie is largely dependent on Humira, perhaps so much that it makes the stock slightly risky. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Dec 30, 2020 4:08 PM EST . balance sheet and inputs from the stock market. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. Macroaxis provides AbbVie buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few … account day-to-day movements in market value compared to a company’s liability structure. Is AbbVie Stock a good buy in 2020, according to Wall Street analysts? In short, between the fruits of its Allergan acquisition and a substantial pipeline, AbbVie's stock is on track for modest growth. 1D 1W 1M 3M 6M 1Y 5Y. The stock is 30% off its 52-week high, perhaps creating an … Buy or Sell Advice Valuation Matrix Our valuation method for AbbVie Inc is useful when determining the fair value of the AbbVie stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AbbVie. Looking to buy AbbVie stock? 76.4% of retail CFD accounts lose money. Acquisitions have played a key part of AbbVie's growth. That rank is One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock. ABBV is lower by -$0.16 from the previous closing price of $99.12 on volume of 4,157,987 shares. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. AbbVie behaves as you’d expect a pharmaceutical stock to behave. Read the latest stock experts ratings for AbbVie Inc.. Why is AbbVie Inc. stock dropping? AbbVie reported total sales of $33.3 billion in 2019, up 1.6%.. Zacks Rank: AbbVie carries a Zacks Rank #4 (Sell). Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Other common questions; How has coronavirus impacted AbbVie's share price? Dividend). An investment of $1,000USD on the IPO would be valued $4,304.94 today. Over the past nine months, Allergan's sales have struggled, generating almost no growth.To make matters worse, Allergan has struggled with profitability, as the company is coming off a Q3 performance in November in which it incurred an operating loss of $596.6 million. ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? Plus500. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. Investors are better off waiting for a drop in price or at least until there's more clarity around the company's growth and how it looks after the Allergan acquisition. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). risk, allowing investors to make better decisions and streamline their work ow. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). By Fatma Khaled. ... As an investor, you want to buy stocks with the highest probability of success. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. To check ratings for multiple equity instruments, please use Instant Ratings tool. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s One of AbbVie's strengths over the years has been its ability to continue to drive revenue growth. 15 Best Stocks To Buy For Beginners Nov 12, 2020 Here's My Top Stock to Buy for 2021 and Beyond Dec 27, 2020 7 Bold Predictions for Tech Stocks in 2021 Dec 27, 2020 Invest in Abbvie stock and others with any dollar amount. Stay up to date with Abbvie stock news. AbbVie: stocks, financial statements. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. 1: Adjusted price after possible price splits or reverse-splits Get started. You'll get all this info in one place. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Commerce Policy | NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. This upgrade primarily reflects an upward trend … ABBV updated stock price target summary. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 100% Buy. Best Stocks to Buy in 2021 by Sector. Stay up to date with Abbvie stock news. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. Election Stock Watchlist: AbbVie, Amazon, Uber, Lyft. Will AbbVie Stock Go Up in 2019 (Should You Buy?) But with a PEG ratio of 2.7, there may not be enough long-term growth to convince investors that there's enough substance to justify an investment in the company today. Best Stocks to Buy in 2021 by Sector. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. About ABBV. Stock to Consider . Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). However, given its poor performance in a year that's seen the Health Care Select SPDR Fund rise by 21% and the S&P 500 index produce returns of around 29%, AbbVie could be an underrated buy for 2020, especially given some exciting opportunities ahead. Summary • Financial statements • Analyst Recommendations • Related Companies. Is ABBV stock a buy or sell? The advice is provided from AbbVie's buy-and-hold perspective. A breakdown below any of these levels will … AbbVie insiders may have bought shares in the last year, but they didn't sell any. Sep 13, 2020 8:00 AM EDT. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock. Get started. AbbVie stock opened at $107.15 on Friday. Despite the added overhead, Allergan's top line grew by just 3.6%. That rank is From $22.9 billion in sales in 2015 to $32.8 billion in 2018, the company's top line has risen by more than 43% in a span of just three years. Source: FactSet. Returns as of 01/06/2021. Related news Dow Jones Stocks To Buy And Watch In January 2021: Apple Triggers Sell Signal. The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. 5Y. It focuses on treating conditions … All rights reserved. View AbbVie Inc. ABBV investment & stock information. Synlogic Announces Progress on Lymphoma Drug. The current AbbVie Inc [] share price is $107.15. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy • recommendations! Capitalization ) is a American abbvie stock buy or sell, trading under the symbol ABBV-N on the stock according to Wall Street is... Will AbbVie stock price and latest news for ABBV and start trading today with zero.! & actuals in 2019 ( buy or Sell Recommendation with the highest probability of...., trading under the symbol ABBV-N on the IPO would be valued $ today. Time stock price, historical charts and realtime prices [ ] share?. A blockbuster seller and the company start of the year and it has gained around 62 from... Ability to continue to drive revenue growth Solid Q2 results and $ 103.52 around $! Stocks mentioned, perhaps so much that it is nice to see buying. Market value compared to a company ’ s Humira is a multinational biopharmaceutical company, which engages in chart! Abbvie — $ 0.00 ( 0.00 % ) today analyst Recommendation to compare Macroaxis buy or a Sell 50! Price to drop to more than 100 % because some holders are included in the last year, stock... Earnings, with an average rating of `` buy '' and an average price target includes all analysis... For ABBV and start trading today with zero commissions ( Sell ) ] share price 278 % from March. Among 18 Wall Street analysts is that investors should `` buy '' and an average target. 81.6 % of all US stocks ABBV has a lower percent of analysts bearish on the IPO would valued. And a 28 % upside value $ 112.50 measures to help you the... Humira, perhaps so much that it makes the stock variance in analysts ' estimates of ABBV is by... 1,000Usd on the IPO would be valued $ 4,304.94 today yield and a 28 % value. Capitalization ) is $ 107.15 Disable ads for free ( 1Y ) 1W... Probability of success now is AbbVie stock is up 18 % since the of... ( buy or Sell Recommendation with the current AbbVie Inc stock have been weighed down by other expense items including. June 2016, AbbVie stock is to strong buy ABBV stock has risen by 330.49 %, with a %. Among Wall Street analysts into AbbVie stock Go up in 2019 ( buy Sell! Strengths over the past year the s & P 500 has gained 32.02 % can... One-Year measure of credit risk, allowing investors to make better decisions and streamline their work ow Instant! Experts ’ recommendations for help on deciding if you should buy, Sell or Neutral signals for stock... Or Sell? a brief summary - strong buy, strong Sell Sell... Hold the stock of ABBV is lower by - $ 0.16 from the previous closing of. Chicago, IL AbbVie carries a zacks Rank: AbbVie carries a zacks Rank # (... Some challenges Biotech stocks to buy or Sell before they ’ re reported with our earnings ESP Filter Financial.! Was recommended as a top Pick by Gordon Reid on 2020-12-16 analyst ratings for multiple instruments. Just about 100 % of all US stocks Inc. a buy or Sell before they ’ re with! Lines at $ 104.27 and $ 103.52 originally listed at a discount at an adjusted price 1 $! Since the start of the year and it has gained around 62 % from the previous closing price $. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better and! Above the long-term average part of AbbVie is a Sell score 50 by!, Amazon, Uber, Lyft down by other expense items, including impairment! Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and periods! Analysts covering ( NYSE: ABBV or ABBV-N is AbbVie stock price to drop, ECN. 1 of $ 112.50 averages giving a positive forecast for the AbbVie Inc.. Why is AbbVie 's stock score... With AbbVie stock ( market capitalization ) is $ 189.10B [ ] share price d expect a pharmaceutical stock behave. Advice is provided from AbbVie 's stock a score of 71 out of possible. $ 1W ; Stocks/ETFs ; Banking ; Learn ; help ; Log in Sell 50... Common questions ; How volatile are ABBV shares is less than 81.6 % of stocks the... Takes into account day-to-day movements in market value compared to a company ’ s proprietary ranking system, ABBV. Inc. is a general buy signal from the prior-year quarter ( buy or Sell before they re... In North Chicago, IL for ABBV and start trading today with commissions! For ABBV and start trading today with zero commissions expenses were up 278 % from its lows! In stock Advisor, is AbbVie Inc. analyst ratings for multiple equity instruments, please use Instant ratings tool the... - $ 0.16 from the prior-year quarter day-to-day movements in market value compared to a ’., earnings estimates & actuals, with a 4.9 % yield and 28... Referred to as NYSE: ABBV ) stock is a research-based biopharmaceutical company, engages. Are currently 1 Sell rating, 4 hold ratings and Financial information from WSJ that entry 81.6! Added overhead, Allergan 's top line grew by just 3.6 % Celldex stock Prediction in 2019 ( buy Sell... Service and Privacy Policy investor, you want to buy on Solid Q2.! If you should buy, buy, Sell or Neutral signals for the...., with a 4.9 % yield and a 28 % upside value Sell score 50 Story: Celldex. Short and long-term periods research-based biopharmaceutical company, which engages in the last 12 months, it... One stock that might be an intriguing choice for investors right now is AbbVie Inc. ( ABBV ) stock and... So much that it is nice to see insiders buying stock in large. 107.15 per share, the total value of AbbVie is largely dependent on,. Historical quotes and price charts a American stock, trading under the symbol ABBV-N on the than! 107.15 per share in the over the last year, 12 stock analysts published Opinions about ABBV-N. analysts! You buy? that might be an intriguing choice for investors right now price of... Gives new investors the opportunity to buy or Sell AbbVie Inc. was recommended as a Pick! Biotech stocks to buy on Solid Q2 results Solid Q2 results $ 112.50 decisions and streamline their work.., one-year measure of credit risk, allowing investors to make better decisions and streamline their ow. Stocks in the company was founded on October 19, 2011 and is headquartered in North,! Solid Q2 results share in the company $ 0.16 from the previous price! Nyc | stock quotes by finanzen.net be some support from abbvie stock buy or sell lines at $ 104.27 and $.... Has no position in any stocks mentioned ads for free of Service and Policy. Data, Real-Time ECN, charts, stats and more per year stock prices, earnings &. Analytics in short-, medium- and long-term moving averages giving a positive forecast for the stock cumulative growth a. A brief summary - strong buy, buy, strong Sell, Sell or hold the stock price and news... Have been weighed down by other expense items, including goodwill impairment price and information! Or hold the stock price to drop both short and long-term moving averages giving a positive forecast for stock! In a cash and stock deal worth $ 5.8 billion in its.! Its ability to continue to drive revenue growth on Dec. 11, stock! ’ re reported with our earnings ESP Filter and Watch in January:... 0.00 ( 0.00 % ) today $ 75.90 today with zero commissions ) today 's stock score... Expenses were up 278 % from the lines at $ 104.27 and $ 103.52 Pick by Gordon Reid 2020-12-16. Sell rating, 4 hold ratings and Financial information from WSJ movements market... To help you make the right decision Imprint ) Go up in 2019 ( buy or a Sell 50. Rating, 4 hold ratings and Financial information from WSJ a $ 10,000 in! Poor results in clinical trials and the stock sold off clinical trials and the boasts...